Ken Lim

Ken Lim serves as CSL's Chief Financial Officer.

Ken is a long-time CSL leader who has served in multiple leadership positions across a range of businesses. He was appointed CFO in October 2025 after being Chief Strategy Officer since August 2023.

Prior to these current roles, Ken held several positions at CSL Seqirus, including Head of Strategy & Finance and interim General Manager.

Ken joined CSL in 2013 as Vice President of Strategic Projects where he focused on the company’s strategy, business development, and mergers & acquisitions. He was involved in several key strategic partnerships and acquisitions, including CSL’s acquisition of the Novartis influenza business in 2015 which then became CSL Seqirus.

Before joining CSL, Ken advised CSL on several strategic initiatives as a Merrill Lynch investment banker, including CSL’s purchase of Aventis Behring in 2004 which became CSL Behring.

Ken began his career as a solicitor with Mallesons Stephen Jaques, a large commercial law firm in Australia, where he specialized in corporate law. Ken gained a Bachelor of Commerce and Bachelor of Laws (Honours), from Monash University in Melbourne, Australia.